The acquisition of the remaining 25% stake will allow Bayer to gain complete control over BZPPL, in accordance with the pre-agreed terms of the joint venture.
Bayer acquires remaining 25 percent stake in Bayer Zydus Pharma for Rs 282 crores financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited (BZPPL), established in 2011 for pharmaceutical sales and marketing in India. Bayer is now acquiring full ownership of the entity as per pre-agreed terms. The joint venture successfully combined Zydus s Indian marketing expertise and distribution network with Bayer s global innovation, making strides in various therapeutic areas.
The 50:50 joint venture was established on January 28, 2011, for the sales and marketing of pharmaceutical products in India. Bayer is now securing full ownership of the entity, as per pre-agreed JV terms.
Bayer launches therapy for diabetes-related kidney disease tribune.net.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribune.net.ph Daily Mail and Mail on Sunday newspapers.